| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | actomyosin | 1.17e-05 | 117 | 53 | 5 | GO:0042641 | |
| GeneOntologyCellularComponent | condensed chromosome | 1.23e-04 | 307 | 53 | 6 | GO:0000793 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 1.57e-04 | 107 | 53 | 4 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 1.57e-04 | 107 | 53 | 4 | GO:0001725 | |
| GeneOntologyCellularComponent | actin filament bundle | 2.28e-04 | 118 | 53 | 4 | GO:0032432 | |
| GeneOntologyCellularComponent | cell leading edge | 2.56e-04 | 500 | 53 | 7 | GO:0031252 | |
| GeneOntologyCellularComponent | actin filament | 5.13e-04 | 146 | 53 | 4 | GO:0005884 | |
| GeneOntologyCellularComponent | Z disc | 5.82e-04 | 151 | 53 | 4 | GO:0030018 | |
| GeneOntologyCellularComponent | chromosome, centromeric region | 6.62e-04 | 276 | 53 | 5 | GO:0000775 | |
| GeneOntologyCellularComponent | supramolecular fiber | 6.64e-04 | 1179 | 53 | 10 | GO:0099512 | |
| GeneOntologyCellularComponent | chromosomal region | 6.64e-04 | 421 | 53 | 6 | GO:0098687 | |
| GeneOntologyCellularComponent | supramolecular polymer | 6.99e-04 | 1187 | 53 | 10 | GO:0099081 | |
| GeneOntologyCellularComponent | I band | 8.29e-04 | 166 | 53 | 4 | GO:0031674 | |
| GeneOntologyCellularComponent | GABA-A receptor complex | 1.05e-03 | 19 | 53 | 2 | GO:1902711 | |
| GeneOntologyCellularComponent | GABA receptor complex | 1.28e-03 | 21 | 53 | 2 | GO:1902710 | |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 1.45e-03 | 193 | 53 | 4 | GO:0000779 | |
| GeneOntologyCellularComponent | microtubule plus-end | 2.29e-03 | 28 | 53 | 2 | GO:0035371 | |
| GeneOntologyCellularComponent | perinuclear endoplasmic reticulum | 2.45e-03 | 29 | 53 | 2 | GO:0097038 | |
| GeneOntologyCellularComponent | actin cytoskeleton | 3.26e-03 | 576 | 53 | 6 | GO:0015629 | |
| GeneOntologyCellularComponent | sarcomere | 3.64e-03 | 249 | 53 | 4 | GO:0030017 | |
| GeneOntologyCellularComponent | nuclear chromosome | 3.91e-03 | 254 | 53 | 4 | GO:0000228 | |
| GeneOntologyCellularComponent | microtubule end | 4.18e-03 | 38 | 53 | 2 | GO:1990752 | |
| GeneOntologyCellularComponent | myofibril | 5.04e-03 | 273 | 53 | 4 | GO:0030016 | |
| GeneOntologyCellularComponent | axonal growth cone | 5.82e-03 | 45 | 53 | 2 | GO:0044295 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 6.08e-03 | 46 | 53 | 2 | GO:0005790 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 6.23e-03 | 290 | 53 | 4 | GO:0043292 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | 7.30e-03 | 899 | 53 | 7 | GO:0099513 | |
| GeneOntologyCellularComponent | U2-type precatalytic spliceosome | 7.43e-03 | 51 | 53 | 2 | GO:0071005 | |
| GeneOntologyCellularComponent | A band | 7.71e-03 | 52 | 53 | 2 | GO:0031672 | |
| GeneOntologyCellularComponent | precatalytic spliceosome | 8.30e-03 | 54 | 53 | 2 | GO:0071011 | |
| Domain | GABAAa_rcpt | 1.09e-04 | 6 | 51 | 2 | IPR001390 | |
| Domain | GABAA/Glycine_rcpt | 1.78e-03 | 23 | 51 | 2 | IPR006028 | |
| Domain | SNF2_N | 3.44e-03 | 32 | 51 | 2 | IPR000330 | |
| Domain | SNF2_N | 3.44e-03 | 32 | 51 | 2 | PF00176 | |
| Domain | Neurotransmitter_ion_chnl_CS | 6.71e-03 | 45 | 51 | 2 | IPR018000 | |
| Domain | PH | 6.93e-03 | 278 | 51 | 4 | SM00233 | |
| Domain | Neur_chan_memb | 7.01e-03 | 46 | 51 | 2 | PF02932 | |
| Domain | PH_DOMAIN | 7.02e-03 | 279 | 51 | 4 | PS50003 | |
| Domain | PH_domain | 7.11e-03 | 280 | 51 | 4 | IPR001849 | |
| Domain | Neur_chan_LBD | 7.31e-03 | 47 | 51 | 2 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 7.31e-03 | 47 | 51 | 2 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 7.31e-03 | 47 | 51 | 2 | IPR006029 | |
| Domain | - | 7.31e-03 | 47 | 51 | 2 | 2.70.170.10 | |
| Domain | Neur_channel | 7.31e-03 | 47 | 51 | 2 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 7.31e-03 | 47 | 51 | 2 | IPR006202 | |
| Pathway | BIOCARTA_FLUMAZENIL_PATHWAY | 2.13e-04 | 9 | 35 | 2 | M22034 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 2.66e-04 | 10 | 35 | 2 | MM1401 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 2.66e-04 | 10 | 35 | 2 | M477 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 22763624 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 14766194 | ||
| Pubmed | Molecular and neuronal substrate for the selective attenuation of anxiety. | 2.37e-06 | 2 | 54 | 2 | 11021797 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 24553732 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 23147414 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 22666188 | ||
| Pubmed | Functional mapping of GABA A receptor subtypes in the amygdala. | 2.37e-06 | 2 | 54 | 2 | 15341600 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 8391122 | ||
| Pubmed | Reversal of pathological pain through specific spinal GABAA receptor subtypes. | 2.37e-06 | 2 | 54 | 2 | 18202657 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 23067879 | ||
| Pubmed | Enrichment of GABAA Receptor α-Subunits on the Axonal Initial Segment Shows Regional Differences. | 2.37e-06 | 2 | 54 | 2 | 26973458 | |
| Pubmed | 3.96e-06 | 20 | 54 | 3 | 33397958 | ||
| Pubmed | 6.66e-06 | 169 | 54 | 5 | 31462741 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 16835366 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 27128218 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 15304513 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 1356407 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 15017002 | ||
| Pubmed | ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. | 1.01e-05 | 27 | 54 | 3 | 17525332 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 1.26e-05 | 934 | 54 | 9 | 33916271 | |
| Pubmed | Association study between GABA receptor genes and anxiety spectrum disorders. | 1.42e-05 | 4 | 54 | 2 | 19842164 | |
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 25865415 | ||
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 25080596 | ||
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 26518133 | ||
| Pubmed | GABA(A) receptor downregulation in brains of subjects with autism. | 1.42e-05 | 4 | 54 | 2 | 18821008 | |
| Pubmed | 1.86e-05 | 209 | 54 | 5 | 36779422 | ||
| Pubmed | Itch suppression in mice and dogs by modulation of spinal α2 and α3GABAA receptors. | 2.36e-05 | 5 | 54 | 2 | 30104684 | |
| Pubmed | 3.54e-05 | 6 | 54 | 2 | 20457185 | ||
| Pubmed | An EB1-binding motif acts as a microtubule tip localization signal. | 3.54e-05 | 6 | 54 | 2 | 19632184 | |
| Pubmed | Modelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5. | 3.54e-05 | 6 | 54 | 2 | 15033447 | |
| Pubmed | 3.54e-05 | 6 | 54 | 2 | 8626794 | ||
| Pubmed | 4.05e-05 | 246 | 54 | 5 | 15345747 | ||
| Pubmed | 4.94e-05 | 7 | 54 | 2 | 7560270 | ||
| Pubmed | 4.94e-05 | 7 | 54 | 2 | 16101898 | ||
| Pubmed | Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia. | 4.94e-05 | 7 | 54 | 2 | 20843900 | |
| Pubmed | 4.94e-05 | 7 | 54 | 2 | 35228700 | ||
| Pubmed | Control of a neuronal morphology program by an RNA-binding zinc finger protein, Unkempt. | 6.41e-05 | 271 | 54 | 5 | 25737280 | |
| Pubmed | 6.58e-05 | 1442 | 54 | 10 | 35575683 | ||
| Pubmed | 6.59e-05 | 8 | 54 | 2 | 11309420 | ||
| Pubmed | 6.59e-05 | 8 | 54 | 2 | 8175718 | ||
| Pubmed | 6.59e-05 | 8 | 54 | 2 | 11528422 | ||
| Pubmed | The cell adhesion molecule nectin-1 is critical for normal enamel formation in mice. | 8.46e-05 | 9 | 54 | 2 | 18703497 | |
| Pubmed | 1.06e-04 | 10 | 54 | 2 | 36733270 | ||
| Pubmed | Functional modifications of acid-sensing ion channels by ligand-gated chloride channels. | 1.06e-04 | 10 | 54 | 2 | 21789198 | |
| Pubmed | 1.06e-04 | 10 | 54 | 2 | 29617460 | ||
| Pubmed | 1.29e-04 | 11 | 54 | 2 | 39137998 | ||
| Pubmed | 1.29e-04 | 11 | 54 | 2 | 1421760 | ||
| Pubmed | Review: Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis. | 1.29e-04 | 11 | 54 | 2 | 9924185 | |
| Pubmed | Region and layer-specific expression of GABAA receptor isoforms and KCC2 in developing cortex. | 1.29e-04 | 11 | 54 | 2 | 38894703 | |
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | 1.30e-04 | 315 | 54 | 5 | 26777405 | |
| Pubmed | Amelogenesis imperfecta in a new animal model--a mutation in chromosome 5 (human 4q21). | 1.55e-04 | 12 | 54 | 2 | 15271968 | |
| Pubmed | Chromosomal localization of GABAA receptor subunit genes: relationship to human genetic disease. | 1.55e-04 | 12 | 54 | 2 | 2561974 | |
| Pubmed | 1.55e-04 | 12 | 54 | 2 | 35472321 | ||
| Pubmed | 1.83e-04 | 13 | 54 | 2 | 22569571 | ||
| Pubmed | 1.83e-04 | 13 | 54 | 2 | 22640814 | ||
| Pubmed | 1.92e-04 | 777 | 54 | 7 | 35844135 | ||
| Pubmed | 2.03e-04 | 347 | 54 | 5 | 17114649 | ||
| Pubmed | Developmental expression of the oligodendrocyte myelin glycoprotein in the mouse telencephalon. | 2.13e-04 | 14 | 54 | 2 | 19892785 | |
| Pubmed | The WTX Tumor Suppressor Interacts with the Transcriptional Corepressor TRIM28. | 2.45e-04 | 15 | 54 | 2 | 25882849 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 2.53e-04 | 197 | 54 | 4 | 20811636 | |
| Pubmed | 2.80e-04 | 16 | 54 | 2 | 25987543 | ||
| Pubmed | 3.56e-04 | 18 | 54 | 2 | 19078961 | ||
| Pubmed | 3.56e-04 | 18 | 54 | 2 | 18985723 | ||
| Pubmed | 3.98e-04 | 19 | 54 | 2 | 20504901 | ||
| Pubmed | 4.42e-04 | 20 | 54 | 2 | 22504172 | ||
| Pubmed | 4.58e-04 | 1497 | 54 | 9 | 31527615 | ||
| Pubmed | 4.88e-04 | 21 | 54 | 2 | 25708312 | ||
| Pubmed | The FNIP co-chaperones decelerate the Hsp90 chaperone cycle and enhance drug binding. | 4.88e-04 | 21 | 54 | 2 | 27353360 | |
| Pubmed | 5.36e-04 | 22 | 54 | 2 | 38736483 | ||
| Pubmed | SOCS2 Binds to and Regulates EphA2 through Multiple Mechanisms. | 6.79e-04 | 110 | 54 | 3 | 28883622 | |
| Pubmed | 7.30e-04 | 261 | 54 | 4 | 33277362 | ||
| Pubmed | 7.51e-04 | 26 | 54 | 2 | 25228645 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 8.16e-04 | 1294 | 54 | 8 | 30804502 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 9.86e-04 | 283 | 54 | 4 | 30585729 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 9.96e-04 | 1024 | 54 | 7 | 24711643 | |
| Pubmed | MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer. | 1.04e-03 | 287 | 54 | 4 | 36180891 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 1.05e-03 | 498 | 54 | 5 | 36634849 | |
| Pubmed | Celf4 controls mRNA translation underlying synaptic development in the prenatal mammalian neocortex. | 1.36e-03 | 35 | 54 | 2 | 37758766 | |
| Pubmed | 1.36e-03 | 35 | 54 | 2 | 22337587 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 1.37e-03 | 1082 | 54 | 7 | 38697112 | |
| Pubmed | 1.47e-03 | 538 | 54 | 5 | 28524877 | ||
| Pubmed | Heart neurons use clock genes to control myocyte proliferation. | 1.52e-03 | 37 | 54 | 2 | 34851661 | |
| Cytoband | 2p16.3 | 3.09e-04 | 22 | 54 | 2 | 2p16.3 | |
| Cytoband | 1p36.22 | 8.81e-04 | 37 | 54 | 2 | 1p36.22 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 5.09e-04 | 19 | 32 | 2 | 563 | |
| GeneFamily | X-linked mental retardation|Angiotensin receptors | 3.95e-03 | 53 | 32 | 2 | 103 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 5.67e-03 | 206 | 32 | 3 | 682 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | DST NEBL ATRX MYO5A NEXMIF RTN4 DOCK10 FNIP1 CLASP2 PTGES3 FAM219A | 2.43e-06 | 946 | 53 | 11 | M39169 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | 2.48e-05 | 818 | 52 | 10 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#3_top-relative-expression-ranked_500 | 4.19e-05 | 79 | 52 | 4 | gudmap_developingGonad_P2_ovary_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.62e-05 | 168 | 52 | 5 | gudmap_developingGonad_P2_ovary_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | 9.39e-05 | 770 | 52 | 9 | gudmap_developingGonad_P2_ovary_1000 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 1.98e-06 | 170 | 54 | 5 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-06 | 173 | 54 | 5 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-06 | 173 | 54 | 5 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-06 | 173 | 54 | 5 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.22e-06 | 174 | 54 | 5 | 412ccc099028a372b9d953363984c2da54b2187f | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 3.32e-06 | 189 | 54 | 5 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 3.59e-06 | 192 | 54 | 5 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 3.87e-06 | 195 | 54 | 5 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 4.06e-06 | 197 | 54 | 5 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | Basal_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 3.75e-05 | 155 | 54 | 4 | 30accc72a6a914ae0c4d52b373ea1c9a98efbf22 | |
| ToppCell | AT1-AT2_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.04e-05 | 158 | 54 | 4 | 3bc51cfd37b289cc3e866b54ce55a298e5eff690 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.24e-05 | 160 | 54 | 4 | 0293b244c063a62819690bf22bbc2681f8d15252 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.24e-05 | 160 | 54 | 4 | 3eaae86fa08f7651021316f8e5811bf48055591e | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.56e-05 | 163 | 54 | 4 | 99cf60dc87f7ce288553091bffcd85109a02bd8f | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.56e-05 | 163 | 54 | 4 | 510c0af66e82c5a8cf8edd0547dae4018a87dbbf | |
| ToppCell | CV-Mild-3|Mild / Virus stimulation, Condition and Cluster | 4.89e-05 | 166 | 54 | 4 | 5599f90fc0e15a3670b03187085eba91228390a2 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.37e-05 | 170 | 54 | 4 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.01e-05 | 175 | 54 | 4 | bbce8b1a160b414c0bf643c21c4e5e78fbccb7e1 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.01e-05 | 175 | 54 | 4 | fd8b5b756f3df4a04938785f3d9edbb6f1cd20f6 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro-stroma-schwann_cells|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.01e-05 | 175 | 54 | 4 | 8b010220cdfb680ec839572f4933adfb85045ea6 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.01e-05 | 175 | 54 | 4 | 36c140540497bbe1c5f08fac2d94f08cac18fabb | |
| ToppCell | 10x3'2.3-week_17-19-Neuro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.01e-05 | 175 | 54 | 4 | 0b579aeadcc06be83627391c0b01bd8605fdbdf3 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 176 | 54 | 4 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.42e-05 | 178 | 54 | 4 | c7e890cd02206c516cf1d7692ea7abc8ce746482 | |
| ToppCell | wk_08-11-Epithelial-PNS-Proliferating_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.56e-05 | 179 | 54 | 4 | ab23fee9adab1e63d5b5cd9faba6b9a92beef425 | |
| ToppCell | 10x5'-blood-Lymphocytic_NK-Cycling_NK|blood / Manually curated celltypes from each tissue | 6.56e-05 | 179 | 54 | 4 | c93711273055a999335ba8d0f6500e4549f46cec | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-1|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 6.56e-05 | 179 | 54 | 4 | 431e1b29015ec817f778499106d24b19cfc825ae | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.85e-05 | 181 | 54 | 4 | fad7ba168f541ac9d04edebc206f191e48bb7e99 | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.00e-05 | 182 | 54 | 4 | b1e66ccd5f33b4801f1cafddf97f5fc0c6dba8d1 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.15e-05 | 183 | 54 | 4 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 7.30e-05 | 184 | 54 | 4 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | facs-Heart-LA-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-05 | 185 | 54 | 4 | 1ecfca049c0c1110fd1b2256db7cb7abda6afb04 | |
| ToppCell | facs-Heart-LA-18m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-05 | 185 | 54 | 4 | b6df1412b579d40ed5df806f9c54bd1fbb9a1e15 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.45e-05 | 185 | 54 | 4 | 56c7a0dbf141728ac76b8c90af197719942ca67c | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.77e-05 | 187 | 54 | 4 | dfc2b95d70daf533bc0cc4ce78af9f65dd75a25b | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.77e-05 | 187 | 54 | 4 | f0c6e53035b00772377c4d5f761b4d11026b911a | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 7.77e-05 | 187 | 54 | 4 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.77e-05 | 187 | 54 | 4 | f20e7a1751694390f535ffb27b97e887220f8695 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.77e-05 | 187 | 54 | 4 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 7.77e-05 | 187 | 54 | 4 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic-Cycling_Dendritic|Lung / Manually curated celltypes from each tissue | 7.93e-05 | 188 | 54 | 4 | 0e8ac42c439f30a05e015210e1d5c2dcb9d9d471 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.26e-05 | 190 | 54 | 4 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 8.26e-05 | 190 | 54 | 4 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 8.26e-05 | 190 | 54 | 4 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 8.26e-05 | 190 | 54 | 4 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 8.43e-05 | 191 | 54 | 4 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.43e-05 | 191 | 54 | 4 | 4bfdf44d4402a42530d30c89d94946acdda4321b | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.43e-05 | 191 | 54 | 4 | a53616c84178eb6c29b48662358765b082df3f97 | |
| ToppCell | (3)_Macrophage_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.43e-05 | 191 | 54 | 4 | b42f0b89bb94fd43786ff50f1caeb3ebfbbb43fd | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.43e-05 | 191 | 54 | 4 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.60e-05 | 192 | 54 | 4 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.78e-05 | 193 | 54 | 4 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.78e-05 | 193 | 54 | 4 | d0a5f212f8e8a13dbbe3e41df92548ef82eef70b | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.78e-05 | 193 | 54 | 4 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.78e-05 | 193 | 54 | 4 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.78e-05 | 193 | 54 | 4 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 8.78e-05 | 193 | 54 | 4 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 8.78e-05 | 193 | 54 | 4 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.78e-05 | 193 | 54 | 4 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.95e-05 | 194 | 54 | 4 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 8.95e-05 | 194 | 54 | 4 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.95e-05 | 194 | 54 | 4 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 9.13e-05 | 195 | 54 | 4 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 9.13e-05 | 195 | 54 | 4 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 9.13e-05 | 195 | 54 | 4 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | (1)_T_cells-(1)_T_cells_Dividing|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 9.13e-05 | 195 | 54 | 4 | cf00a0b4f341f0487d5b37810abe2952fdd3f6f2 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 9.13e-05 | 195 | 54 | 4 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-MK-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.32e-05 | 196 | 54 | 4 | 66ba31b74953726e9c314f6d8fe3f75d3762e23a | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.32e-05 | 196 | 54 | 4 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.32e-05 | 196 | 54 | 4 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.32e-05 | 196 | 54 | 4 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.32e-05 | 196 | 54 | 4 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | (3)_MNP-(3)_Macrophage_Dividing|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 9.50e-05 | 197 | 54 | 4 | 048bc4f8fd5d4f394e2384700640f72042336597 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.50e-05 | 197 | 54 | 4 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer|World / Primary Cells by Cluster | 9.50e-05 | 197 | 54 | 4 | 41e823b14697827f657b13adb3afa581bd91a9cb | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.50e-05 | 197 | 54 | 4 | cd7e34318b4ae72b7b312fda8cc0e041c2ac4ab5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.50e-05 | 197 | 54 | 4 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 9.50e-05 | 197 | 54 | 4 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 9.50e-05 | 197 | 54 | 4 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.50e-05 | 197 | 54 | 4 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.69e-05 | 198 | 54 | 4 | 22559b161e67b49fe8028bfaf861e069063599f5 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 9.69e-05 | 198 | 54 | 4 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.69e-05 | 198 | 54 | 4 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.69e-05 | 198 | 54 | 4 | c506334d81af672ef9ddc8c4fd2a790bdb58e63e | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.69e-05 | 198 | 54 | 4 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | ILEUM-non-inflamed-(6)_ILC-(6)_ILC3|(6)_ILC / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.88e-05 | 199 | 54 | 4 | ba144739f65560207303c0143e8de1e86922bebb | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.88e-05 | 199 | 54 | 4 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | ILEUM-inflamed-(6)_ILC-(6)_ILC3|(6)_ILC / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.88e-05 | 199 | 54 | 4 | 02879df850b0c72b57d7b22cfc43f3407e182dcb | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.88e-05 | 199 | 54 | 4 | 06cf08b4a60670f583895a79488524b7b386b2f0 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.88e-05 | 199 | 54 | 4 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 9.88e-05 | 199 | 54 | 4 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 9.88e-05 | 199 | 54 | 4 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | Macroglial-Oligodendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.01e-04 | 200 | 54 | 4 | 4dbac2f2587e87ca5a0622f50439bb5447e93c7f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 200 | 54 | 4 | 741e59c68ae4a3a7be830e98771a14f920c9e883 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.01e-04 | 200 | 54 | 4 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-04 | 200 | 54 | 4 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.01e-04 | 200 | 54 | 4 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 200 | 54 | 4 | 55b7b17f2d413b9ebb262ef8bd210ef45618a7f3 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.01e-04 | 200 | 54 | 4 | 26b989e30bbbaf30904ced03f6aae3dea25c732c | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.01e-04 | 200 | 54 | 4 | a510deaada669e690329183e18df02870bd204b3 | |
| Drug | Zolpidem | 1.59e-05 | 3 | 53 | 2 | DB00425 | |
| Drug | Flumazenil | 3.18e-05 | 4 | 53 | 2 | DB01205 | |
| Drug | etizolam | 3.18e-05 | 4 | 53 | 2 | ctd:C044610 | |
| Drug | Eszopiclone | 5.29e-05 | 5 | 53 | 2 | DB00402 | |
| Drug | Zopiclone | 5.29e-05 | 5 | 53 | 2 | DB01198 | |
| Drug | Lorazepam | 5.29e-05 | 5 | 53 | 2 | ctd:D008140 | |
| Drug | Meprobamate | 7.93e-05 | 6 | 53 | 2 | DB00371 | |
| Drug | Flunitrazepam | 7.93e-05 | 6 | 53 | 2 | DB01544 | |
| Drug | propofol | 8.16e-05 | 191 | 53 | 5 | CID000004943 | |
| Drug | Quazepam | 1.11e-04 | 7 | 53 | 2 | DB01589 | |
| Drug | Adinazolam | 1.48e-04 | 8 | 53 | 2 | DB00546 | |
| Drug | Fludiazepam | 1.48e-04 | 8 | 53 | 2 | DB01567 | |
| Drug | Clotiazepam | 1.48e-04 | 8 | 53 | 2 | DB01559 | |
| Drug | Cinolazepam | 1.48e-04 | 8 | 53 | 2 | DB01594 | |
| Drug | Prazepam | 1.48e-04 | 8 | 53 | 2 | DB01588 | |
| Drug | Estazolam | 1.48e-04 | 8 | 53 | 2 | DB01215 | |
| Drug | Halazepam | 1.48e-04 | 8 | 53 | 2 | DB00801 | |
| Drug | 1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane | 1.48e-04 | 8 | 53 | 2 | ctd:C091518 | |
| Drug | tiotidine | 1.89e-04 | 9 | 53 | 2 | ctd:C023990 | |
| Drug | Ethchlorvynol | 1.89e-04 | 9 | 53 | 2 | DB00189 | |
| Drug | Diazepam | 1.89e-04 | 9 | 53 | 2 | DB00829 | |
| Drug | Razoxane | 1.91e-04 | 48 | 53 | 3 | ctd:D011929 | |
| Drug | Secobarbital | 2.36e-04 | 10 | 53 | 2 | DB00418 | |
| Drug | Chlordiazepoxide | 2.36e-04 | 10 | 53 | 2 | DB00475 | |
| Drug | Metharbital | 2.36e-04 | 10 | 53 | 2 | DB00463 | |
| Drug | Pentobarbital | 2.36e-04 | 10 | 53 | 2 | DB00312 | |
| Drug | Talbutal | 2.36e-04 | 10 | 53 | 2 | DB00306 | |
| Drug | Clobazam | 2.36e-04 | 10 | 53 | 2 | DB00349 | |
| Drug | Butalbital | 2.36e-04 | 10 | 53 | 2 | DB00241 | |
| Drug | Butabarbital | 2.36e-04 | 10 | 53 | 2 | DB00237 | |
| Drug | Bromazepam | 2.36e-04 | 10 | 53 | 2 | DB01558 | |
| Drug | Barbituric acid derivative | 2.36e-04 | 10 | 53 | 2 | DB01496 | |
| Drug | Barbital | 2.36e-04 | 10 | 53 | 2 | DB01483 | |
| Drug | Hexobarbital | 2.36e-04 | 10 | 53 | 2 | DB01355 | |
| Drug | Aprobarbital | 2.36e-04 | 10 | 53 | 2 | DB01352 | |
| Drug | Amobarbital | 2.36e-04 | 10 | 53 | 2 | DB01351 | |
| Drug | Heptabarbital | 2.36e-04 | 10 | 53 | 2 | DB01354 | |
| Drug | Butethal | 2.36e-04 | 10 | 53 | 2 | DB01353 | |
| Drug | Clonazepam | 2.36e-04 | 10 | 53 | 2 | DB01068 | |
| Drug | Methylphenobarbital | 2.36e-04 | 10 | 53 | 2 | DB00849 | |
| Drug | Oxazepam | 2.36e-04 | 10 | 53 | 2 | DB00842 | |
| Drug | Primidone | 2.36e-04 | 10 | 53 | 2 | DB00794 | |
| Drug | Midazolam | 2.36e-04 | 10 | 53 | 2 | DB00683 | |
| Drug | Flurazepam | 2.36e-04 | 10 | 53 | 2 | DB00690 | |
| Drug | D-tryptophan methyl ester | 2.89e-04 | 11 | 53 | 2 | CID000077980 | |
| Drug | Thiopental | 2.89e-04 | 11 | 53 | 2 | DB00599 | |
| Drug | Alprazolam | 2.89e-04 | 11 | 53 | 2 | DB00404 | |
| Drug | aluminum sulfate solution | 2.89e-04 | 11 | 53 | 2 | CID000062129 | |
| Drug | Temazepam | 2.89e-04 | 11 | 53 | 2 | DB00231 | |
| Drug | Nitrazepam | 2.89e-04 | 11 | 53 | 2 | DB01595 | |
| Drug | Lorazepam | 2.89e-04 | 11 | 53 | 2 | DB00186 | |
| Drug | Phenobarbital | 2.89e-04 | 11 | 53 | 2 | DB01174 | |
| Drug | galactosylarabinose | 2.89e-04 | 11 | 53 | 2 | CID000193417 | |
| Drug | Triazolam | 2.89e-04 | 11 | 53 | 2 | DB00897 | |
| Drug | Clorazepate | 2.89e-04 | 11 | 53 | 2 | DB00628 | |
| Disease | Neuroblastoma | 8.87e-05 | 47 | 54 | 3 | C0027819 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DMFTESDDMFAAYFD | 631 | Q13523 | |
| DDNTYSLELFEEMRS | 196 | Q9P2W7 | |
| DQETMAFEAEFQYAE | 446 | Q9BRD0 | |
| MEEEAETEEQQRFSY | 1 | Q8N2Z9 | |
| RTYDADMTTSVDFQE | 396 | Q9NP70 | |
| TDRSTFFEEHMDYEY | 1006 | Q8IUA7 | |
| DAMSSSYESYDEEEE | 116 | Q8N556 | |
| MDNYTSDEDIDEDFD | 1 | A6NK59 | |
| FEEMFASRFTENDKE | 11 | Q9BTL3 | |
| DYREESEEYMAAADE | 466 | Q16625 | |
| SFDFEDVERYTMEVE | 306 | Q9Y5F9 | |
| SLFDSDVDMDDYTDH | 391 | Q5TGI0 | |
| SESEYEEYTDSEDEM | 181 | P55081 | |
| FSVQSESYSVEDMDE | 6 | Q96JG8 | |
| YFADQDQFDMVSDAD | 71 | Q9P2W1 | |
| MTFDADRDEDEVFYD | 296 | Q9Y6K8 | |
| REMFSQFAEFDDELD | 5181 | Q03001 | |
| YMDERRDFTYDSVDF | 416 | O43451 | |
| SRMEVDDYSQYEEES | 811 | Q4FZB7 | |
| SDTDMEYTIDVFFRQ | 81 | P47869 | |
| VSEEMDERFRYESDF | 326 | Q1MSJ5 | |
| LDTDSDDDFDMSRYS | 111 | Q8IW50 | |
| SDTDMEYTIDVFFRQ | 106 | P34903 | |
| MDSEAQEDTREAYDD | 36 | A6NDL7 | |
| EDDMEYLTQAAFFEE | 381 | C9JSJ3 | |
| EDEDTEYFDAMEDST | 446 | Q969R2 | |
| SHESFYDSLSDMQEE | 6 | Q8WX93 | |
| LQVDFYTDMDEDSDI | 36 | Q9UHV8 | |
| YTDMDEDSDIAFRFR | 41 | Q9UHV8 | |
| YFDEDSMDEFIASDS | 1901 | P46100 | |
| DYEEMSFHDDQGSFV | 706 | A4D2P6 | |
| REDESSSMFDEYFQE | 266 | Q9UHW5 | |
| TYFVLAAETESDMDE | 266 | Q96BY6 | |
| HYNSFEEDELMEFSE | 1056 | Q8TD26 | |
| RDSTFVFMEGSEDAY | 326 | Q86XK2 | |
| SMSLFDEYFNDDSIE | 831 | Q8TF40 | |
| SFENREEDMIDTFQF | 486 | Q5T5S1 | |
| ADDRDDYDFLMQTST | 1411 | Q92736 | |
| MDYSIEEDDSQTFDI | 291 | Q9H159 | |
| TSCEAYEEDRETFMN | 146 | P02771 | |
| FTQDEYFAMVAENES | 171 | O14654 | |
| DRDLTEFSELEYSEM | 286 | Q9NQC3 | |
| EMETAFNSRGFEDSY | 306 | Q17RD7 | |
| DMTEDELREFFSQYG | 201 | Q13148 | |
| FVAGEDDMTDSLRDY | 371 | Q6DKJ4 | |
| FSEEDVDNYMFDDDE | 286 | Q5QGS0 | |
| DYDTENMNSEDIYSS | 926 | O75122 | |
| EFSFDFTREQLMEEN | 1416 | A0JNW5 | |
| VESYSFEARMEVDAD | 31 | Q96E35 | |
| DDSDEDMSNFDRFSE | 111 | Q15185 | |
| RQDSEDHSSDMFNYE | 116 | O43291 | |
| FTMDLDSDEDFSDFD | 1326 | P11388 | |
| LEMFYNDNDRVEESS | 26 | Q5T7P6 | |
| ETLSTYDENTRDFMF | 96 | Q9NWH7 | |
| YTLEDQDREFMVFAD | 81 | Q9HAW7 | |
| ESEYIFSSEIAEMED | 1121 | Q9Y4I1 | |
| AMYDYSAQDEDEVSF | 961 | O76041 |